Arrhythmia recurrence following PVI with cardioneuromodulation: insights from a cohort of patients with both bradycardia and paroxysmal atrial fibrillation
In this study, CNM was safe and produced measurable autonomic modulation in 2/3 of patients, captured by an immediate stable heart-rate rise >10 bpm, and emerged as marker of higher recurrence risk.